We are live on ! Find out more
SCM

Snyder Capital Management Portfolio holdings

AUM $5.16B
1-Year Est. Return 26.72%
This Fund
S&P 500
This Quarter Est. Return
-1.27%
1 Year Est. Return
+26.72%
3 Year Est. Return
+66.88%
5 Year Est. Return
+92.49%
10 Year Est. Return
+485.74%
AUM
$4.58B
AUM Growth
-$209M
Cap. Flow
-$66.8M
Cap. Flow %
-1.46%
Top 10 Hldgs %
36.89%
Holding
69
New
Increased
18
Reduced
50
Closed
1

Top Buys

Rank Stock Value
1
FMC icon
FMC
FMC
+$18.1M
2
ENTG icon
Entegris
ENTG
+$15.2M
3
VRRM icon
Verra Mobility
VRRM
+$10.4M
4
COHR icon
Coherent
COHR
+$8.58M
5
RTO icon
Rentokil
RTO
+$7.69M

Top Sells

Rank Stock Value
1
HALO icon
Halozyme
HALO
+$28.7M
2
CGNX icon
Cognex
CGNX
+$12.5M
3
APH icon
Amphenol
APH
+$10.6M
4
WWD icon
Woodward
WWD
+$7.59M
5
INGR icon
Ingredion
INGR
+$7.13M

Sector Composition

Rank Sector Weight
1 Industrials 38.98%
2 Technology 18.74%
3 Financials 13.4%
4 Healthcare 10.87%
5 Materials 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NNN icon
51
NNN REIT
NNN
$9.01B
$31.5M 0.69%
738,626
-15,543
-2% -$634K
RTO icon
52
Rentokil
RTO
$12.5B
$29.3M 0.64%
1,278,062
+318,481
+33% +$7.69M
IQV icon
53
IQVIA
IQV
$38.9B
$27.7M 0.61%
157,353
+474
+0.3% +$92K
AGYS icon
54
Agilysys
AGYS
$3.12B
$27.3M 0.6%
376,070
+21,945
+6% +$2.01M
KEYS icon
55
Keysight
KEYS
$57.4B
$27.2M 0.6%
181,854
+45,459
+33% +$7.51M
FCN icon
56
FTI Consulting
FCN
$4.23B
$27.1M 0.59%
165,111
-5,328
-3% -$958K
VVV icon
57
Valvoline
VVV
$4.72B
$27M 0.59%
776,657
+127,113
+20% +$4.64M
CRL icon
58
Charles River Laboratories
CRL
$12.6B
$26.2M 0.57%
174,259
-3,668
-2% -$615K
WEX icon
59
WEX
WEX
$6.42B
$23.3M 0.51%
148,561
-3,064
-2% -$505K
TMO icon
60
Thermo Fisher Scientific
TMO
$214B
$23.1M 0.5%
46,353
+135
+0.3% +$73.1K
MKL icon
61
Markel Group
MKL
$23.3B
$19.9M 0.44%
10,651
-222
-2% -$408K
DORM icon
62
Dorman Products
DORM
$4.2B
$18.9M 0.41%
156,434
-32,024
-17% -$4.09M
FAF icon
63
First American
FAF
$7.66B
$18.7M 0.41%
285,162
-68,381
-19% -$4.33M
PDFS icon
64
PDF Solutions
PDFS
$2.07B
$14.4M 0.31%
753,610
-25,444
-3% -$624K
HXL icon
65
Hexcel
HXL
$7.89B
$13.3M 0.29%
243,435
-5,124
-2% -$320K
PPBI
66
DELISTED
Pacific Premier Bancorp
PPBI
$11.3M 0.25%
528,799
-17,848
-3% -$425K
CXT icon
67
Crane NXT
CXT
$3.01B
$10.9M 0.24%
211,295
-6,944
-3% -$407K
CGNX icon
68
Cognex
CGNX
$11.8B
$7.09M 0.15%
237,604
-355,866
-60% -$12.5M
CDMO
69
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
-311,008
Closed -$3.84M

Similar funds

Snyder Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Snyder Capital Management held 69 positions worth $4.58B, down 4.4% from $4.78B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 1.4%. Snyder Capital Management opened no new positions and exited 1, leaving the 69-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 39% of assets, down from 40% a quarter earlier, followed by Technology and Financials.

  • Snyder Capital Management added most to FMC in Q1 2025, an estimated $18.1M increase.
  • Snyder Capital Management's biggest Q1 2025 reduction was Halozyme, cutting an estimated $28.7M.
  • Snyder Capital Management fully exited Avid Bioservices, Inc. Common Stock in Q1 2025, selling an estimated $3.84M.
  • Snyder Capital Management's ten largest holdings make up 37% of its $4.58B portfolio in Q1 2025.
  • Snyder Capital Management opened 0 new positions and closed 1 in Q1 2025.
  • Snyder Capital Management's portfolio value fell 4.4% quarter-over-quarter to $4.58B.

Based on Snyder Capital Management's 13F filing for Q1 2025, filed 15 May 2025.